UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Neothetics (NEOT)

Neothetics (NEOT)
1.92 +0.08 (+4.35%) 01/17/18 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Wed, Jan 17th, 2018
Day Low
1.84
Day High
1.94
Open 1.90
Previous Close 1.84 1.84
Volume 152,800 152,800
Avg Vol 276,510 276,510
Stochastic %K 36.55% 36.55%
Weighted Alpha +223.70 +223.70
5-Day Change -0.04 (-2.04%) -0.04 (-2.04%)
52-Week Range 0.30 - 2.63 0.30 - 2.63
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,592
  • Shares Outstanding, K 13,850
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,020 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 3.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.49
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.55
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/09/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.55 +23.87%
on 12/18/17
Period Open: 1.64
2.15 -10.70%
on 01/04/18
+0.28 (+17.07%)
since 12/15/17
3-Month
1.03 +86.41%
on 10/24/17
Period Open: 1.72
2.15 -10.70%
on 01/04/18
+0.20 (+11.63%)
since 10/17/17
52-Week
0.30 +540.00%
on 09/07/17
Period Open: 1.18
2.63 -27.00%
on 05/25/17
+0.74 (+62.71%)
since 01/17/17

Business Summary

Neothetics, Inc. is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. The Company is focused on localized fat reduction and body contouring. Its lead product candidate, LIPO-202, is for the reduction of central abdominal bulging due to subcutaneous fat...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 2.00
1st Resistance Point 1.96
Last Price 1.92
1st Support Level 1.86
2nd Support Level 1.80
3rd Support Level N/A

See More

52-Week High 2.63
Last Price 1.92
Fibonacci 61.8% 1.74
Fibonacci 50% 1.47
Fibonacci 38.2% 1.19
52-Week Low 0.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar